Filings For: Supernus Pharmaceuticals, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 9/11/2026 4:53:18 PM   View Proxy SEC Y 2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/3/2026 7:02:45 AM Mid View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $219,058,000 +32.4% Assets $1,428,109,000 EPS -$1.01
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/3/2026 6:48:21 AM   View Financials Earnings SEC 2Q 2026 Rev $219,058,000 +32.4% Assets $1,428,109,000 EPS -$1.01 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/5/2026 4:26:39 PM Mid View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $207,705,000 +38.6% Assets $1,500,725,000 EPS -$0.04
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/5/2026 4:11:44 PM   View Financials Earnings SEC 1Q 2026 Rev $207,705,000 +38.6% Assets $1,500,725,000 EPS -$0.04 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/30/2026 6:41:12 PM   View Proxy SEC Y 2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 3/2/2026 4:53:32 PM Mid View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $718,952,000 +8.6% Assets $1,452,648,000 EPS -$0.68
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/24/2026 4:16:42 PM   View Financials Earnings SEC Y 2025 Rev $211,572,000 +21.5% Assets $1,452,648,000 EPS -$0.07 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/6/2025 5:16:09 PM Mid View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $192,103,000 +9.3% Assets $1,419,754,000 EPS -$0.80
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/4/2025 4:28:24 PM   View Financials Earnings SEC 3Q 2025 Rev $192,103,000 +9.3% Assets $1,419,754,000 EPS -$0.80 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/5/2025 4:33:52 PM   View Financials Earnings SEC 2Q 2025 Rev $165,453,000 -1.7% Assets $1,382,405,000 EPS $0.40 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/5/2025 4:32:14 PM Mid View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $165,453,000 -1.7% Assets $1,382,405,000 EPS $0.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/6/2025 4:32:17 PM Mid View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $149,824,000 +4.3% Assets $1,347,290,000 EPS -$0.21
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/6/2025 4:14:52 PM   View Financials Earnings SEC 1Q 2025 Rev $149,824,000 +4.3% Assets $1,347,290,000 EPS -$0.21 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/30/2025 4:58:09 PM   View Proxy SEC Y 2024
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/25/2025 4:25:40 PM Mid View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $661,817,000 +8.9% Assets $1,368,073,000 EPS $1.32
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/25/2025 4:08:17 PM   View Financials Earnings SEC Y 2024 Rev $174,159,000 +6.0% Assets $1,368,073,000 EPS $0.27 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/4/2024 4:30:43 PM Mid View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $175,689,000 +14.2% Assets $1,342,701,000 EPS $0.69
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/4/2024 4:17:54 PM   View Financials Earnings SEC 3Q 2024 Rev $175,689,000 +14.2% Assets $1,342,701,000 EPS $0.69 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/6/2024 4:29:42 PM Mid View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $168,325,000 +24.2% Assets $1,315,829,000 EPS $0.36
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/6/2024 4:17:09 PM   View Financials Earnings SEC 2Q 2024 Rev $168,325,000 +24.2% Assets $1,315,829,000 EPS $0.36 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/8/2024 4:25:43 PM Mid View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $143,644,000 -6.6% Assets $1,304,090,000
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/8/2024 4:11:00 PM   View Financials Earnings SEC 1Q 2024 Rev $143,644,000 -6.6% Assets $1,304,090,000 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/29/2024 4:29:24 PM   View Proxy SEC Y 2023
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/28/2024 4:06:10 AM Mid View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $607,521,000 -8.9% Assets $1,277,673,000 EPS $0.02
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/27/2024 4:21:40 PM   View Financials Earnings SEC Y 2023 Rev $164,314,000 -1.8% Assets $1,277,673,000 EPS $0.02 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/8/2023 4:29:11 PM Mid View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $153,880,000 -13.2% Assets $1,285,160,000 EPS -$0.29
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/8/2023 4:16:30 PM   View Financials Earnings SEC 3Q 2023 Rev $153,880,000 -13.2% Assets $1,285,160,000 EPS -$0.29 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/10/2023 5:16:17 PM   View Correction SEC 2Q 2023
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/8/2023 4:47:09 PM Mid View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $135,563,000 -20.3% Assets $1,293,099,000 EPS -$0.02
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/8/2023 4:38:51 PM   View Financials Earnings SEC 2Q 2023 Rev $135,563,000 -20.3% Assets $1,293,099,000 EPS -$0.02 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/9/2023 4:34:25 PM Mid View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Rev: $153,764,000 +0.8% Assets $1,791,808,000 EPS $0.29
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/9/2023 4:21:19 PM   View Financials Earnings SEC 1Q 2023 Rev $153,764,000 +0.8% Assets $1,791,808,000 EPS $0.29 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/1/2023 4:08:48 PM   View Proxy SEC Y 2022
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 3/9/2023 4:30:33 PM Mid View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $667,238,000 +15.1% Assets $1,702,508,000 EPS $1.04
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/28/2023 5:11:00 PM   View Financials Earnings SEC Y 2022 Rev $167,328,000 +5.2% Assets $1,702,508,000 EPS $0.42 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/9/2022 5:16:48 PM Mid View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Rev: $177,353,000 +19.5% Assets $1,693,129,000 EPS $0.03
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/8/2022 5:11:52 PM   View Financials Earnings SEC 3Q 2022 Rev $177,353,000 +19.5% Assets $1,693,129,000 EPS $0.03 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/8/2022 4:38:47 PM Mid View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Rev: $170,051,000 +20.3% Assets $1,694,973,000 EPS $0.14
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/4/2022 5:10:08 PM   View Financials Earnings SEC 2Q 2022 Rev $170,051,000 +20.3% Assets $1,694,973,000 EPS $0.14 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/12/2022 5:29:59 PM Mid View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $152,506,000 +16.5% Assets $1,639,517,000 EPS $0.43
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/9/2022 5:23:44 PM   View Financials Earnings SEC 1Q 2022 Rev $152,506,000 +16.5% Assets $1,639,517,000 EPS $0.43 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/2/2022 4:02:10 PM   View Proxy SEC Y 2021
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/13/2022 4:18:48 PM   View Financials Earnings SEC 1Q 2022 Rev $152,506,000 +16.5% Assets $1,639,517,000 EPS $0.43 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/13/2022 4:16:56 PM Mid View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $579,775,000 +11.4% Assets $1,689,152,000 EPS $0.98
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/28/2022 5:24:26 PM   View Financials Earnings (Prelim) SEC Y 2021 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/5/2021 4:21:27 PM Mid View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Rev: $148,464,000 -4.3% Assets $1,555,040,000 EPS $0.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/4/2021 6:03:24 AM   View Financials Earnings SEC 3Q 2021 Rev $148,464,000 -4.3% Assets $1,555,040,000 EPS $0.40 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/6/2021 1:03:55 PM Mid View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $141,329,000 +11.5% Assets $1,573,060,000 EPS $0.43
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/4/2021 5:29:43 PM   View Financials Earnings SEC 2Q 2021 Rev $141,329,000 +11.5% Assets $1,573,060,000 EPS $0.43 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/7/2021 5:02:57 PM Mid View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $130,932,000 +37.9% Assets $1,507,443,000 EPS $0.11
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/5/2021 5:12:46 PM   View Financials Earnings SEC 1Q 2021 Rev $130,932,000 +37.9% Assets $1,507,443,000 EPS $0.11 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/30/2021 2:32:38 PM   View Proxy SEC Y 2020
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 3/8/2021 4:45:23 PM Mid View Financials 10-K SEC Y 2020 ending: 12/31/2020 Rev: $520,397,000 +32.5% Assets $1,504,102,000 EPS $2.36
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/26/2021 6:05:44 AM   View Financials Earnings SEC Y 2020 Rev $143,557,000 +42.9% Assets $1,504,102,000 EPS $0.57 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/6/2020 3:48:26 PM Mid View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Rev: $155,135,000 +51.9% Assets $1,510,022,000 EPS $0.74
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/4/2020 6:01:47 AM   View Financials Earnings SEC 3Q 2020 Rev $155,135,000 +51.9% Assets $1,510,022,000 EPS $0.74 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/19/2020 6:02:06 AM   View Financials Earnings SEC 2Q 2020 Rev $126,729,000 +21.0% Assets $1,491,020,000 EPS $0.65 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/17/2020 5:05:53 PM Mid View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Rev: $126,729,000 +21.0% Assets $1,491,020,000 EPS $0.65
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/11/2020 4:36:36 PM   View Financials Earnings (Prelim) SEC 2Q 2020 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/15/2020 4:45:55 PM Mid View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Rev: $94,976,000 +11.1% Assets $1,189,866,000 EPS $0.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 5/7/2020 9:30:06 AM   View Financials Earnings SEC 1Q 2020 Rev $94,976,000 +11.1% Assets $1,189,866,000 EPS $0.40 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 4/24/2020 9:27:03 AM   View Proxy SEC Y 2019
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/28/2020 1:17:54 PM Mid View Financials 10-K SEC Y 2019 ending: 12/31/2019 Rev: $392,755,000 -3.9% Assets $1,160,282,000 EPS $2.10
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 2/27/2020 4:37:36 PM   View Financials Earnings SEC Y 2019 Rev $100,446,000 -13.4% Assets $1,160,282,000 EPS $0.62 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/8/2019 4:13:27 PM Mid View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Rev: $102,140,000 -0.8% Assets $1,106,909,000 EPS $0.54
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 11/6/2019 5:16:42 PM   View Financials Earnings SEC 3Q 2019 Rev $102,140,000 -0.8% Assets $1,106,909,000 EPS $0.54 Export Earnings Model
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/9/2019 11:14:31 AM Mid View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Rev: $104,695,000 +5.2% Assets $1,063,675,000 EPS $0.61
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8/6/2019 4:58:24 PM   View Financials Earnings SEC 2Q 2019 Rev $104,695,000 +5.2% Assets $1,063,675,000 EPS $0.61 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/10/2019 4:03:21 PM Mid View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Rev: $85,474,000 -5.5% Assets $1,025,448,000 EPS $0.34
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/7/2019 5:32:31 PM   View Financials Earnings SEC 1Q 2019 Rev $85,474,000 -5.5% Assets $1,025,448,000 EPS $0.34 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/29/2019 4:32:22 PM   View Proxy SEC Y 2018
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/1/2019 2:32:13 PM Mid View Financials 10-K SEC Y 2018 ending: 12/31/2018 Rev: $408,897,000 +35.3% Assets $977,811,000 EPS $2.05
SUPERNUS PHARMACEUTICALS INC (SUPN) 2/26/2019 5:20:12 PM   View Financials Earnings SEC Y 2018 Rev $115,934,000 +31.1% Assets $977,811,000 EPS $0.48 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/9/2018 9:58:31 AM Mid View Financials 10-Q SEC 3Q 2018 ending: 9/30/2018 Rev: $102,996,000 +28.1% Assets $922,512,000 EPS $0.52
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/6/2018 4:59:32 PM   View Financials Earnings SEC 3Q 2018 Rev $102,996,000 +28.1% Assets $922,512,000 EPS $0.52 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/9/2018 4:10:38 PM Mid View Financials 10-Q SEC 2Q 2018 ending: 6/30/2018 Rev: $99,538,000 +31.3% Assets $852,799,000 EPS $0.57
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/7/2018 5:32:27 PM   View Financials Earnings SEC 2Q 2018 Rev $99,538,000 +31.3% Assets $852,799,000 EPS $0.57 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/10/2018 2:14:02 PM Mid View Financials 10-Q SEC 1Q 2018 ending: 3/31/2018 Rev: $90,429,000 +57.1% Assets $825,160,000 EPS $0.49
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/8/2018 5:26:26 PM   View Financials Earnings SEC 1Q 2018 Rev $90,429,000 +57.1% Assets $825,160,000 EPS $0.49 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/27/2018 5:41:54 PM   View Proxy SEC Y 2017
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/1/2018 5:22:38 PM Small View Financials 10-K SEC Y 2017 ending: 12/31/2017 Rev: $302,238,000 +40.6% Assets $424,464,000 EPS $1.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 2/27/2018 4:56:32 PM   View Financials Earnings SEC Y 2017 Rev $88,435,000 +41.8% Assets $424,464,000 EPS $0.26 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/9/2017 6:15:52 AM Small View Financials 10-Q SEC 3Q 2017 ending: 9/30/2017 Rev: $80,398,000 +41.5% Assets $385,478,000 EPS $0.29
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/6/2017 7:00:14 PM   View Financials Earnings SEC 3Q 2017 Rev $80,398,000 +41.5% Assets $385,478,000 EPS $0.29 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/3/2017 3:55:04 PM Small View Financials 10-Q SEC 2Q 2017 ending: 6/30/2017 Rev: $75,829,000 +46.9% Assets $346,370,000 EPS $0.32
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/2/2017 4:57:03 PM   View Financials Earnings SEC 2Q 2017 Rev $75,829,000 +46.9% Assets $346,370,000 EPS $0.32 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/9/2017 5:24:52 PM Small View Financials 10-Q SEC 1Q 2017 ending: 3/31/2017 Rev: $57,576,000 +30.3% Assets $322,256,000 EPS $0.19
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/9/2017 4:37:41 PM   View Financials Earnings SEC 1Q 2017 Rev $57,576,000 +30.3% Assets $322,256,000 EPS $0.19 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/27/2017 4:39:05 PM   View Proxy SEC Y 2016
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/26/2017 4:39:00 PM   View Financials Earnings SEC 1Q 2017 Rev $57,576,000 +30.3% Assets $322,256,000 EPS $0.19 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/16/2017 4:17:20 PM Small View Financials 10-K SEC Y 2016 ending: 12/31/2016 Rev: $215,003,000 +45.8% Assets $309,568,000 EPS $1.76
SUPERNUS PHARMACEUTICALS INC (SUPN) 2/28/2017 9:09:11 PM   View Financials Earnings SEC Y 2016 Rev $62,374,000 +42.8% Assets $309,568,000 EPS $0.26 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 1/23/2017 5:30:00 AM Small View Financials 10-Q/A SEC 2Q 2016 ending: 6/30/2016 Rev: $51,626,000 +44.7% Assets $218,633,000 EPS $0.18
SUPERNUS PHARMACEUTICALS INC (SUPN) 1/20/2017 5:31:43 PM Small View Financials 10-Q SEC 3Q 2016 ending: 9/30/2016 Rev: $56,810,000 +44.3% Assets $285,116,000 EPS $1.18
SUPERNUS PHARMACEUTICALS INC (SUPN) 1/20/2017 5:28:15 PM Small View Financials 10-Q/A SEC 1Q 2016 ending: 3/31/2016 Rev: $44,194,000 +53.8% Assets $194,474,000 EPS $0.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 1/20/2017 5:27:29 PM Small View Financials 10-K/A SEC Y 2015 ending: 12/31/2015 Rev: $147,465,000 +59.1% Assets $188,626,000 EPS $0.28
SUPERNUS PHARMACEUTICALS INC (SUPN) 1/20/2017 5:26:50 PM Small View Financials 10-Q/A SEC 3Q 2015 ending: 9/30/2015 Rev: $39,362,000 +73.5% Assets $166,641,000 EPS $0.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/5/2016 5:30:00 AM Small View Financials 10-Q SEC 2Q 2016 ending: 6/30/2016 Rev: $51,626,000 +44.7% Assets $218,633,000 EPS $0.18
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/2/2016 5:06:05 PM   View Financials Earnings SEC 2Q 2016 Rev $51,626,000 +44.7% Assets $218,633,000 EPS $0.18 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/10/2016 5:30:00 AM Small View Financials 10-Q SEC 1Q 2016 ending: 3/31/2016 Rev: $44,194,000 +53.8% Assets $194,474,000 EPS $0.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/3/2016 6:19:18 PM   View Financials Earnings SEC 1Q 2016 Rev $44,194,000 +53.8% Assets $194,474,000 EPS $0.08 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/19/2016 5:23:39 PM   View Proxy SEC Y 2015
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/9/2016 5:30:00 AM Small View Financials 10-K SEC Y 2015 ending: 12/31/2015 Rev: $147,465,000 +59.1% Assets $188,626,000 EPS $0.28
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/2/2016 6:45:28 PM   View Financials Earnings SEC Y 2015 Rev $43,687,000 +39.9% Assets $188,626,000 EPS $0.14 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/9/2015 4:52:04 PM Small View Financials 10-Q SEC 3Q 2015 ending: 9/30/2015 Rev: $39,362,000 +73.5% Assets $166,641,000 EPS $0.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/3/2015 6:02:39 PM   View Financials Earnings SEC 3Q 2015 Rev $39,362,000 +73.5% Assets $166,641,000 EPS $0.08 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/7/2015 5:30:00 AM Small View Financials 10-Q SEC 2Q 2015 ending: 6/30/2015 Rev: $35,678,000 +20.2% Assets $154,014,000 EPS $0.04
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/4/2015 9:25:03 PM   View Financials Earnings SEC 2Q 2015 Rev $35,678,000 +20.2% Assets $154,014,000 EPS $0.04 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 7/20/2015 4:41:49 PM   View Financials Earnings SEC 2Q 2015 Rev $35,678,000 +20.2% Assets $154,014,000 EPS $0.04 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/6/2015 5:27:39 PM Micro View Financials 10-Q SEC 1Q 2015 ending: 3/31/2015 Rev: $28,738,000 +216.5% Assets $139,405,000 EPS $0.02
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/5/2015 5:01:47 PM   View Financials Earnings SEC 1Q 2015 Rev $28,738,000 +216.5% Assets $139,405,000 EPS $0.02 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/22/2015 4:30:36 PM   View Financials Earnings SEC 1Q 2015 Rev $28,738,000 +216.5% Assets $139,405,000 EPS $0.02 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/30/2015 4:48:06 PM   View Proxy SEC Y 2014
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/12/2015 4:09:30 PM Micro View Financials 10-K SEC Y 2014 ending: 12/31/2014 Rev: $92,678,000 +671.1% Assets $136,784,000 EPS -$0.26
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/11/2015 4:53:37 PM   View Financials Earnings SEC Y 2014 Rev $31,235,000 +202.2% Assets $136,784,000 EPS $0.09 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/10/2015 5:24:06 PM   View Financials Earnings SEC Y 2014 Rev $31,235,000 +202.2% Assets $136,784,000 EPS $0.09 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 2/19/2015 4:31:33 PM   View Financials Earnings SEC Y 2014 Rev $31,235,000 +202.2% Assets $136,784,000 EPS $0.09 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/12/2014 4:30:46 PM Micro View Financials 10-Q SEC 3Q 2014 ending: 9/30/2014 Rev: $22,687,000 +1,704.9% Assets $125,560,000 EPS -$0.06
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/12/2014 6:34:10 AM   View Financials Earnings SEC 3Q 2014 Rev $22,687,000 +1,704.9% Assets $125,560,000 EPS -$0.06 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/5/2014 4:30:19 PM   View Financials Earnings SEC 3Q 2014 Rev $22,687,000 +1,704.9% Assets $125,560,000 EPS -$0.06 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 10/30/2014 4:30:38 PM   View Financials Earnings SEC 3Q 2014 Rev $22,687,000 +1,704.9% Assets $125,560,000 EPS -$0.06 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/12/2014 4:16:16 PM Micro View Financials 10-Q SEC 2Q 2014 ending: 6/30/2014 Rev: $29,675,000 +10,460.5% Assets $94,190,000 EPS $0.08
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/11/2014 5:20:37 PM   View Financials Earnings SEC 2Q 2014 Rev $29,675,000 +10,460.5% Assets $94,190,000 EPS $0.08 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 7/31/2014 4:37:42 PM   View Financials Earnings SEC 2Q 2014 Rev $29,675,000 +10,460.5% Assets $94,190,000 EPS $0.08 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/13/2014 4:16:01 PM Micro View Financials 10-Q SEC 1Q 2014 ending: 3/31/2014 Rev: $9,081,000 +6,077.6% Assets $97,520,000 EPS -$0.38
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/12/2014 7:00:12 PM   View Financials Earnings SEC 1Q 2014 Rev $9,081,000 +6,077.6% Assets $97,520,000 EPS -$0.38 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/30/2014 12:00:00 AM   View Financials Earnings SEC 1Q 2014 Rev $9,081,000 +6,077.6% Assets $97,520,000 EPS -$0.38 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 4/7/2014 5:02:53 PM   View Proxy SEC Y 2013
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/21/2014 4:48:15 PM Micro View Financials 10-K SEC Y 2013 ending: 12/31/2013 Rev: $12,019,000 +712.1% Assets $110,995,000 EPS -$2.90
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/12/2014 12:00:00 AM   View Financials Earnings SEC Y 2013 Rev $10,335,000 +849.0% Assets $110,995,000 EPS -$0.65 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 2/26/2014 12:00:00 AM   View Financials Earnings SEC Y 2013 Rev $10,335,000 +849.0% Assets $110,995,000 EPS -$0.65 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/13/2013 5:30:00 AM Micro View Financials 10-Q SEC 3Q 2013 ending: 9/30/2013 Rev: $1,257,000 +1,281.3% Assets $123,765,000 EPS -$0.78
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/12/2013 12:00:00 AM   View Financials Earnings SEC 3Q 2013 Rev $1,257,000 +1,281.3% Assets $123,765,000 EPS -$0.78 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/7/2013 12:00:00 AM   View Financials Earnings SEC 3Q 2013 Rev $1,257,000 +1,281.3% Assets $123,765,000 EPS -$0.78 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/14/2013 7:03:55 AM Micro View Financials 10-Q SEC 2Q 2013 ending: 6/30/2013 Rev: $281,000 +208.8% Assets $131,973,000 EPS -$0.89
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/13/2013 12:00:00 AM   View Financials Earnings SEC 2Q 2013 Rev $281,000 +208.8% Assets $131,973,000 EPS -$0.89 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/9/2013 12:00:00 AM   View Financials Earnings SEC 2Q 2013 Rev $281,000 +208.8% Assets $131,973,000 EPS -$0.89 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/15/2013 4:17:38 PM Micro View Financials 10-Q SEC 1Q 2013 ending: 3/31/2013 Rev: $147,000 -29.3% Assets $79,061,000 EPS -$0.60
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/13/2013 12:00:00 AM   View Financials Earnings SEC 1Q 2013 Rev $147,000 -29.3% Assets $79,061,000 EPS -$0.60 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 5/6/2013 12:00:00 AM   View Financials Earnings SEC 1Q 2013 Rev $147,000 -29.3% Assets $79,061,000 EPS -$0.60 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/29/2013 1:23:25 PM   View Proxy SEC Y 2012
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/15/2013 4:20:26 PM Micro View Financials 10-K SEC Y 2012 ending: 12/31/2012 Rev: $1,480,000 +84.3% Assets $93,989,000 EPS -$2.72
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/14/2013 12:00:00 AM   View Financials Earnings SEC Y 2012 Rev $1,089,000 +2,492.9% Assets $93,989,000 EPS -$0.36 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 3/11/2013 12:00:00 AM   View Financials Earnings SEC Y 2012 Rev $1,089,000 +2,492.9% Assets $93,989,000 EPS -$0.36 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/8/2012 12:00:00 AM   View Financials Earnings SEC 3Q 2012 Rev $91,000 +727.3% Assets $67,014,000 EPS -$0.55 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 11/2/2012 5:07:30 PM Micro View Financials 10-Q SEC 3Q 2012 ending: 9/30/2012 Rev: $91,000 +727.3% Assets $67,014,000 EPS -$0.55
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/13/2012 4:52:01 PM Micro View Financials 10-Q SEC 2Q 2012 ending: 6/30/2012 Rev: $91,000 -87.9% Assets $79,965,000 EPS -$0.61
SUPERNUS PHARMACEUTICALS INC (SUPN) 8/10/2012 12:00:00 AM   View Financials Earnings SEC 2Q 2012 Rev $91,000 -87.9% Assets $79,965,000 EPS -$0.61 Export Earnings Model
SUPERNUS PHARMACEUTICALS INC (SUPN) 6/8/2012 4:47:34 PM Micro View Financials 10-Q SEC 1Q 2012 ending: 3/31/2012 Rev: $208,000 Assets $43,202,000 EPS -$6.05
SUPERNUS PHARMACEUTICALS INC (SUPN) 6/7/2012 12:00:00 AM   View Financials Earnings SEC 1Q 2012 Rev $208,000 Assets $43,202,000 EPS -$6.05 Export Earnings Model